Factor H and disease: a complement regulator affects vital body functions

被引:82
作者
Zipfel, PF
Hellwage, J
Friese, MA
Hegasy, G
Jokiranta, ST
Meri, S
机构
[1] Bernhard Nocht Inst Trop Med, Res Grp Biomol Med, D-20539 Hamburg, Germany
[2] Univ Jena, Clin Anestesiol & Intens Care Med, D-07740 Jena, Germany
[3] Univ Helsinki, HD Diagnost, FIN-00290 Helsinki, Finland
[4] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00290 Helsinki, Finland
关键词
D O I
10.1016/S0161-5890(99)00038-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor H is a multidomain and multifunctional protein. As a complement regulator factor H determines the fate of newly formed C3b and controls formation and stability of C3 convertases both in the fluid phase and on cell surfaces. In addition, this plasma protein displays functions outside complement control as it has been suggested to act as an adhesion protein, to be a ligand for the cellular integrin receptor CR3 (CD11b/CD18) and to display chemotactic activity. Genetic and pathophysiological analyses describe a role for factor H in vital body functions. Depletion or the absence of factor H due to genetic reasons leads to unrestricted C3 consumption. A reduced amount of factor H in plasma or mutations within the factor H gene may lead to glomerulonephritis (type II MPGN) or hemolytic uremic syndrome (HUS), Certain pathogenic organisms have been shown to evade complement attack by binding factor H from the host. Such specific factor H binding components have been demonstrated on the surface of microbes, e.g., Streptococcus pyogenes and Neisseria gonorrhoeae, Here, we summarize the current knowledge how abnormalities in function of the central complement regulator factor H are associated with human diseases, (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 61 条
[1]   Human factor H deficiency - Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism [J].
Ault, BH ;
Schmidt, BZ ;
Fowler, NL ;
Kashtan, CE ;
Ahmed, AE ;
Vogt, BA ;
Colten, HR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25168-25175
[2]  
AVERY VM, 1993, J IMMUNOL, V151, P5545
[3]  
Blackmore TK, 1996, J IMMUNOL, V157, P5422
[4]  
Blackmore TK, 1998, J IMMUNOL, V160, P3342
[5]   M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H [J].
Blackmore, TK ;
Fischetti, VA ;
Sadlon, TA ;
Ward, HM ;
Gordon, DL .
INFECTION AND IMMUNITY, 1998, 66 (04) :1427-1431
[6]  
CAMERON JS, 1973, LANCET, V2, P975
[7]   ROLE OF THE YADA-PROTEIN IN PREVENTION OF OPSONIZATION OF YERSINIA-ENTEROCOLITICA BY C3B MOLECULES [J].
CHINA, B ;
SORY, MP ;
NGUYEN, BT ;
DEBRUYERE, M ;
CORNELIS, GR .
INFECTION AND IMMUNITY, 1993, 61 (08) :3129-3136
[8]   MEMBRANE SIALIC-ACID ON TARGET PARTICLES MODULATES THEIR PHAGOCYTOSIS BY A TRYPSIN-SENSITIVE MECHANISM ON HUMAN MONOCYTES [J].
CZOP, JK ;
FEARON, DT ;
AUSTEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (08) :3831-3835
[9]  
Diaz A, 1997, J IMMUNOL, V158, P3779
[10]  
DIAZGUILLEN A, 1988, IN PRESS IMMUNOGENET